Circulating MicroRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes

Peter Willeit*, Philipp Skroblin, Alexander R. Moschen, Xiaoke Yin, Dorothee Kaudewitz, Anna Zampetaki, Temo Barwari, Meredith Whitehead, Cristina M. Ramírez, Leigh Goedeke, Noemi Rotllan, Enzo Bonora, Alun D. Hughes, Peter Santer, Carlos Fernández-Hernando, Herbert Tilg, Johann Willeit, Stefan Kiechl, Manuel Mayr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

197 Citations (Scopus)
59 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Circulating MicroRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science